Juan F. Gallegos-Orozco,
MD
Languages Spoken: English, Spanish
Dr. Juan F. Gallegos-Orozco graduated from medical school in Mexico and completed post-graduate medical education in Internal Medicine and Gastroenterology in both Mexico and the United States, where he completed fellowship training in Transplant Hepatology at the prestigious Mayo School of Graduate Medical Education, Mayo Clinic in Phoenix, Arizona in June 2012. His main clinical and research interests include the management of chronic viral hepatitis, non-alcoholic fatty liver disease and liver transplantation. He has published many research articles on these and other topics and has authored several book chapters pertaining to liver diseases. Dr. Gallegos-Orozco joined the Division of Gastroenterology, Hepatology and Nutrition at the University of Utah School of Medicine in July, 2012 and is currently an Associate Professor of Medicine and serves as the Medical Director for Hepatology and Liver Transplant.
Clinical Locations
Endoscopy
801-213-9797
General Endoscopy
801-213-9797
Kidney and Liver Clinic
801-213-9797
Liver Transplant
801-213-9797
Gastroenterology Endoscopy Center
801-213-9797
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Gastroenterology |
| Board Certification | American Board of Internal Medicine (Sub: Transplant Hepatology) Mexican Board of Gastroenterology Mexican Board of Gastroenterology (Sub: Gastrointestinal Endoscopy) Mexican Board of Internal Medicine |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider's explanation of condition/problem
4.7/ 5
Care provider's effort to include me in decisions
4.7/ 5
Wait time at clinic
4.7/ 5
Care provider's concern for questions & worries
4.8/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
March 23, 2022
UH HOSPITALS AND CLINICS
Dr. Gallegos was very kind. He showed personal interest in me and my family. He seemed very knowledgeable and determined to find the source of my issues.
UofU Patient
March 21, 2022
UH HOSPITALS AND CLINICS
I had a good and professional experience
UofU Patient
March 06, 2022
UH HOSPITALS AND CLINICS
Outstanding help, with the Doctor being well informed about the content of my medical history sent to him by my previous Doctor.
UofU Patient
February 06, 2022
UH HOSPITALS AND CLINICS
Always very impressed with their knowledge and consideration of me
UofU Patient
January 19, 2022
UH HOSPITALS AND CLINICS
Show me concern about my heath and always friendly
UofU Patient
December 14, 2021
UH HOSPITALS AND CLINICS
Great physician.
UofU Patient
December 01, 2021
UH HOSPITALS AND CLINICS
Dr. Gallegos is one of my favorite providers.
UofU Patient
November 13, 2021
UH HOSPITALS AND CLINICS
Good
UofU Patient
August 14, 2021
UH HOSPITALS AND CLINICS
Dr. Gallegos was kind, considerate, and had a plan ready to go for me. The lab orders were put in quickly which I appreciate very much. He was apologetic when the camera malfunctioned on his end. It didn't bother me though. I was comforted in that he knew why I was there what would be best and beneficial for me, let me know what to expect in the future, and what our next few steps would be.
UofU Patient
July 26, 2021
UH HOSPITALS AND CLINICS
My Doctor was able to answer our questions and helped show pictures of my scan I had completed earlier. He also helped clarify about my next appointment. I also was informed about which Covid 19 vaccine was recommended based on my current circumstances. (I forgot to ask my doctor about Ivermectin or hydroxychloroquine, but during our visit, my Doctor did help me know which of the 3 versions I should have with regards to the vaccine.)
UofU Patient
July 01, 2021
UH HOSPITALS AND CLINICS
What I especially like about Dr. Juan Gallegos-Orozco is that he explains and shows me exactly what is happening with my condition. He talks with me so that I know what the best course of healing action is required. Because of this I understand what I need to do to keep my condition stable. I have a strong test and faith in him!
UofU Patient
June 13, 2021
UH HOSPITALS AND CLINICS
very good , easy to talk to and understand.
UofU Patient
May 27, 2021
UH HOSPITALS AND CLINICS
Dr Gallegos is the best
UofU Patient
May 18, 2021
UH HOSPITALS AND CLINICS
Doctor went into a good amount of detail in layman's terms. Felt like I completely understood what was going on and what was needed and why.
UofU Patient
May 15, 2021
UH HOSPITALS AND CLINICS
Dr. G's kindness and professionalism is exceptional and he rubs off on his staff and vise versa. In other words, they have a fabulous virus running rampant in there.! :)
UofU Patient
May 10, 2021
UH HOSPITALS AND CLINICS
Dr. Gonzalez-Orozco, is a much better doctor than my previous liver specialist. he actually listened to me, and his first impression opened the door for trust. The former dr, had me waiting to die and damaged the little trust I had. Dr. Gonzalez-Orozco is helping rebuild that trust, even after one visit. Thanks to Dr. Incze for the recommendation.
UofU Patient
May 08, 2021
UH HOSPITALS AND CLINICS
Dr. Gallegos is great to talk with and thoroughly explains his treatment recommendations in an easily understood manner.
UofU Patient
April 22, 2021
UH HOSPITALS AND CLINICS
Dr. Gallegos is an excellent provider and wonderful human being.
UofU Patient
March 27, 2021
UH HOSPITALS AND CLINICS
Dr Gallegos was wonderful! He listened to all of my crazy questions. He answered each of them and he also listened to my mom and answered her questions!! BEST DOCTOR EVER!!
UofU Patient
March 14, 2021
UH HOSPITALS AND CLINICS
excellent visit
UofU Patient
March 07, 2021
UH HOSPITALS AND CLINICS
First doctor that gave me real answers and hope. Great bedside manner.
UofU Patient
March 06, 2021
UH HOSPITALS AND CLINICS
Best Doctor ever. He saved my life (literally).
UofU Patient
March 03, 2021
UH HOSPITALS AND CLINICS
Dr. Gallegos cares. That's it. He spends as much time as needed, with me, until all my questions are answered and we both feel good about our visit. He's great. I did not have that experience with somebody else who is no longer there. [NAME REMOVED]
UofU Patient
February 28, 2021
UH HOSPITALS AND CLINICS
I asked about results but was informed my primary care physician would discuss with me.
UofU Patient
February 16, 2021
UH HOSPITALS AND CLINICS
I've been a patient with Dr. Gallegos for almost 5 years now, and I'm exceptionally pleased with his approach to my care and his overall partnership in working with me. I couldn't have made a better choice!
UofU Patient
January 11, 2021
UH HOSPITALS AND CLINICS
Dr. Gallegos listened carefully to everything I said, took careful notes, and seemed genuinely concerned. I felt no judgment.
UofU Patient
December 20, 2020
UH HOSPITALS AND CLINICS
The doctor explained the science and medicine extremely well - so well, in fact, that I understand what's going with my condition and what we can do to improve the health outcome.
UofU Patient
December 11, 2020
UH HOSPITALS AND CLINICS
All aspects were good and easy
UofU Patient
December 05, 2020
UH HOSPITALS AND CLINICS
Dr. Gallegos is an excellent provider.He shows concern, interest and empathy for the patient.It's a privilege to have him as my liver doctor.
UofU Patient
November 28, 2020
UH HOSPITALS AND CLINICS
haven't spoken to a care provider about results of procedure yet
UofU Patient
November 27, 2020
UH HOSPITALS AND CLINICS
Dr. Gallegos took time to listen to all my questions and answered them thoroughly.
UofU Patient
November 21, 2020
UH HOSPITALS AND CLINICS
I brought in a list of questions. This was my first real visit with Dr. Gallegos. He was extremely tentative and showed great care and detail in his responses. I left with a happy and open heart for my future in his care. I'm very comfortable with his opinions and knowledge thus far. Thank you :)
UofU Patient
November 05, 2020
UH HOSPITALS AND CLINICS
Always outstanding.
UofU Patient
October 27, 2020
UH HOSPITALS AND CLINICS
Dr. Gallegos is an excellent provider. I wish all doctors were like him.
UofU Patient
October 05, 2020
UH HOSPITALS AND CLINICS
I greatly appreciated the time Dr. Chandna spends explaining results and treatment options. Additionally, his follow up is exceptional. I've had multiple tests lately and he always leaves comments, notes, or next steps in the mychart system so that I know what to do next.
UofU Patient
September 06, 2020
UH HOSPITALS AND CLINICS
Love the people at the U of U medical staff
UofU Patient
August 23, 2020
UH HOSPITALS AND CLINICS
Dr. Gallegos is a compassionate Doctor who cares deeply for his patients. He uses all diagnostic tools to determine any changes in my liver function. He is very concerned about any possibility of liver cancer and monitors so closely that should this be, he will be know immediately and have treatment options available.
UofU Patient
August 23, 2020
UH HOSPITALS AND CLINICS
always informed me about my options
UofU Patient
August 02, 2020
UH HOSPITALS AND CLINICS
Dr. Gallegos is a great provider.He's very caring, professional and a great human being. He shows interest in every concern the pt has.My husband has recommended Dr. Gallegos to people that need care in their liver.
UofU Patient
August 01, 2020
UH HOSPITALS AND CLINICS
Everything from start to finish with my transplant has been excellent!
UofU Patient
July 07, 2020
UH HOSPITALS AND CLINICS
excellent
UofU Patient
July 05, 2020
UH HOSPITALS AND CLINICS
Dr. Gallegos was amazing. He listened and was awesome at explaining what was going on with my health.
Dr. Juan F. Gallegos-Orozco graduated from medical school in Mexico and completed post-graduate medical education in Internal Medicine and Gastroenterology in both Mexico and the United States, where he completed fellowship training in Transplant Hepatology at the prestigious Mayo School of Graduate Medical Education, Mayo Clinic in Phoenix, Arizona in June 2012. His main clinical and research interests include the management of chronic viral hepatitis, non-alcoholic fatty liver disease and liver transplantation. He has published many research articles on these and other topics and has authored several book chapters pertaining to liver diseases. Dr. Gallegos-Orozco joined the Division of Gastroenterology, Hepatology and Nutrition at the University of Utah School of Medicine in July, 2012 and is currently an Associate Professor of Medicine and serves as the Medical Director for Hepatology and Liver Transplant.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Gastroenterology |
| Board Certification | American Board of Internal Medicine (Sub: Transplant Hepatology) Mexican Board of Gastroenterology Mexican Board of Gastroenterology (Sub: Gastrointestinal Endoscopy) Mexican Board of Internal Medicine |
Research Interests
- Liver
- Fatty Liver, Alcoholic
- Liver Cancer
Education History
| Fellowship | Mayo Clinic College of Medicine, Mayo Clinic in Arizona Transplant Hepatology Fellow, 2012 |
| Fellowship | Mayo Clinic College of Medicine, Mayo Clinic in Arizona Gastroenterology Fellow, 2011 |
| Residency | Mayo Clinic College of Medicine Internal Medicine Resident, 2009 |
| Fellowship | Universidad Nacional Autónoma de México Gastroenterology Fellow, 2002 |
| Residency | Universidad Nacional Autónoma de México Internal Medicine Resident, 1999 |
| Professional Medical | Universidad Nacional Autónoma de México Medicine with Honors, (Suma cum Laude equivalent) M.D., 1995 |
| Clerkship | University of New Mexico Hospital, University of New Mexico Medical School Cardiology Clinical Clerkship, 1992 |
| Clerkship | University of New Mexico Hospital, University of New Mexico Medical School Gastroenterology Clinical Clerkship, 1992 |
Selected Publications - Journal Articles
Journal Article
- Wong YJ, Qiu TY, Tam YC, Mohan BP, Gallegos-Orozco JF, Adler DG (2020). Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis. Dig Liver Dis, 52(10), 1137-1142.
- Bajaj JS, Brenner DM, Cai Q, Cash BD, Crowell M, DiBaise J, Gallegos-Orozco JF, Gardner TB, Gyawali CP, Ha C, Holtmann G, Jamil LH, Kaplan GG, Karsan HA, Kinoshita Y, Lebwohl B, Leontiadis GI, Lichtenstein GR, Longstreth GF, Muthusamy VR, Oxentenko AS, Pimentel M, Pisegna JR, Rubenstein JH, Russo MW, Saini SD, Samadder NJ, Shaukat A, Simren M, Stevens T, Valdovinos M, Vargas H, Spiegel B, Lacy BE (2020). Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. Am J Gastroenterol, 115(7), 1007-1018.
- Rofaiel G, Martinez E, Pan G, Sossenheimer M, OHara R, Gallegos J, Box T, Pham T, Campsen J, Goodale M, Kim R (2019). Creation of a Robotically Assisted Terminal Jejunogastrostomy Is Safe and Effective in Regaining Antegrade Enteral Bile Duct Access After Live Donor Liver Transplant With Roux Limb. Transplant Direct, 5(8), e476.
- Garcia-Tsao G, Fuchs M, Shiffman M, Borg BB, Pyrsopoulos N, Shetty K, Gallegos-Orozco JF, Reddy KR, Feyssa E, Chan JL, Yamashita M, Robinson JM, Spada AP, Hagerty DT, Bosch J (2018). Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension. Hepatology, 69(2), 717-728.
- Charlton M, Levitsky J, Aqel B, OGrady J, Hemibach J, Rinella M, Fung J, Ghabril M, Thomason R, Burra P, Little EC, Berenguer M, Shaked A, Trotter J, Roberts J, Rodriguez-Davalos M, Rela M, Pomfret E, Heyrend C, Gallegos-Orozco J, Saliba F (2018). International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation, 102(5), 727-743.
- Gallegos-Orozco JF, Charlton MR (2017). Predictors of Cardiovascular Events After Liver Transplantation. Clin Liver Dis, 21(2), 367-379.
- Samadder NJ, Smith KR, Wong J, Hanson H, Boucher K, Burt RW, Charlton M, Byrne KR, Gallegos-Orozco JF, Koptiuch C, Curtin K (2016). Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah. Dig Dis Sci, 61(12), 3627-3632.
- Gallegos-Orozco JF, Kim R, Thiesset HF, Hatch J, Lynch K, Chaly T Jr, Shihab F, Ahmed F, Hall I, Campsen J (2016). Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation. Cureus, 8(11), e890.
- Gallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, De Petris G, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan DC, Silva AM, Rakela J, Vargas HE (2015). Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdom Imaging, 40(4), 795-802.
- Porres-Aguilar M, Gallegos-Orozco JF (2014). Hepatopulmonary syndrome: Is it time to redefine the MELD exception score for better organ allocation and outcomes? Ann Hepatol, 13(4), 468-70.
- Murad MH, Fernndez-Balsells MM, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Prez L, Ponce de Len-Lovatn PG, Albuquerque FN, Carey J, Erwin PJ, Montori VM (2010). Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin Endocrinol (Oxf), 73(6), 777-91.
- Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE (2009). Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl, 15(12), 1872-81.
Review
- Izzy M, Fortune BE, Serper M, Bhave N, deLemos A, Gallegos-Orozco JF, Guerrero-Miranda C, Hall S, Harinstein ME, Karas MG, Kriss M, Lim N, Palardy M, Sawinski D, Schonfeld E, Seetharam A, Sharma P, Tallaj J, Dadhania DM, VanWagner LB (2022). Management of Cardiac Diseases in Liver Transplant Recipients: Comprehensive Review and Multidisciplinary Practice-Based Recommendations. [Review]. Am J Transplant.
- Chandna S, Zarate ER, Gallegos-Orozco JF (2021). Management of Decompensated Cirrhosis and Associated Syndromes. [Review]. Surg Clin North Am, 102(1), 117-137.
- Chandna S, Rodriguez Zarate E, Gallegos-Orozco JF (2021). Management of decompensated cirrhosis and associated syndromes. [Review]. Surg Clin North Am, 102, 117-137.
- Gallegos-Orozco JF, Charlton M (2017). Predictors of cardiovascular events after liver transplantation. [Review]. Clin Liver Dis, 21(2), 367-379.
- Gallegos-Orozco JF, Charlton MR (2016). Alcoholic Liver Disease and Liver Transplantation. [Review]. Clin Liver Dis, 20(3), 521-34.
- Unzueta A, Gallegos-Orozco JF (2013). Noninvasive diagnosis of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Oncology Gastroenterology Hepatology Reports. [Review]. Oncology, 2, 8-16.
- Porres-Aguilar M, Gallegos-Orozco JF, Garcia H, Aguirre J, Macias-Rodriguez RU, Torre-Delgadillo A (2013). Pulmonary vascular complications in portal hypertension and liver disease: a concise review. [Review]. Rev Gastroenterol Mex, 78(1), 35-44.
- Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM (2012). Chronic constipation in the elderly. [Review]. Am J Gastroenterol, 107(1), 18-25; quiz 26.
Book Chapter
- Unzueta A, Gallegos-Orozco JF (2017). Factores de riesgo en tumores hepaticos [Risk factors for liver tumors]. In Chirino-Sprung RA, Torre-Delgadillo A (Eds.), XII Congreso Nacional de Hepatologia (First, pp. 121-125). Mexico City: Permanyer.
- Unzueta Santos A, Gallegos-Orozco JF (2016). Fibrosis hepática: nuevas alternativas terapéuticas. [Liver fibrosis: new therapeutic options]. In Uscanga L (Ed.), 70 años de Gastroenterología en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán: Los Grandes Temas del Departamento (pp. 13-18). Mexico City, Mexico: Permanyer Mexico.
- Garca Senz de Sicilia M, Gallegos-Orozco JF (2016). Tratamiento actual de la hepatitis crónica por virus de la hepatitis C [Current treatment of chronic hepatitis C]. In Uscanga L. (Ed.), 70 años de Gastroenterología en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán: Los Grandes Temas del Departamento (pp. 119-124). Mexico City, Mexico: Permanyer Mexico.
- Doycheva I, Gallegos-Orozco JF (2016). Acute viral hepatitis: hepatitis A, hepatitis E and other viruses. In Talley NJ, DeVault KR, Wallace MB, Aqel B, Lindor KD (Eds.), Practical Gastroenterology and Hepatology Board Review Toolkit (2nd Edition, pp. 465-72). Oxford: Wiley-Blackwell.
- Gallegos-Orozco JF (2015). Tratamiento actual del enfermo con hepatitis crónica por hepatitis C: un ejemplo de medicina traslacional [Current treatment of chronic hepatitis C: an example of translational medicine]. In Torre A, Uscanga-Domínguez LF (Eds.), Medicina individualizada: de la evidencia a la práctica clínica (pp. 43-49). Mexico City, Mexico: Permanyer Mexico.
- Gallegos-Orozco JF, Campsen J (01/01/2015). Liver transplant-related malignancies. In Busuttil W, Klintmalm GB (Eds.), Transplantation of the Liver (3rd Edition, pp. 1191-1209). Saunders.
- Pham T, Gallegos-Orozco JF (01/01/2014). New treatments for chronic hepatitis C. In Uscanga-Domínguez LF, Yamamoto-Furusho JK (Eds.), Gastroenterología Translacional. La investigación básica al servicio de la práctica clínica. Barcelona: Permanyer Publications.
- Hatch J, Gallegos-Orozco JF (2013). Preoperative evaluation of patients with cirrhosis. In Gonzalez-Huezo MS, Sanchez-Avila JF (Eds.), Hepatología: de la ciencia básica a la aplicación clínica (pp. 107-12). Mexico City: ZarPra Ediciones.
- Porres-Aguilar M, Gallegos-Orozco JF (2013). Pulmonary complications in liver cirrhosis. In Gonzalez-Huezo MS, Sanchez-Avila JF (Eds.), Hepatología: de la ciencia básica a la aplicación clínica (pp. 153-7). Mexico City: ZarPra Ediciones.
- Unzueta A, Gallegos-Orozco JF (2012). Esteatohepatitis no alcohólica, ¿Cuál es el mejor método diagnóstico? In Torre-Delgadillo A, Kershenobich D (Eds.), Tópicos Innovadores en Hepatología (1st Edition, pp. 265-74). Mexico City: ZarPra Ediciones.
- Costilla VC, Gallegos-Orozco JF (2012). Terapias biológicas en el hepatocarcinoma. In Torre-Delgadillo A, Kershenobich D (Eds.), Tópicos Innovadores en Hepatología (1st Edition, pp. 373-88). Mexico City: ZarPra Ediciones.
- Gallegos-Orozco JF, Vargas HE (2012). Drug-Induced, Granulomatous, and Other Inflammatory Hepatic Diseases. In DiBaise J (Ed.), Gastroenterology and Hepatology Board Review: Pearls of Wisdom (3rd Edition, pp. 389-98). New York: McGraw-Hill Medical.
Case Report
- Chaly T, Campsen J, OHara R, Hardman R, Gallegos-Orozco JF, Thiesset H, Kim RD (2017). Mucocele mimicking a gallbladder in a transplanted liver: A case report and review of the literature. World J Transplant, 7(6), 359-363.
- Horner BJ, Craig R, Harris ES, Kovacsovics T, Gallegos-Orozco JF (2017). Acute liver failure secondary to AL amyloidosis. Clin Med Rev Case Rep, 4(2), 157.
- Gallegos-Orozco JF, Gurudu SR, Orenstein R (2012). First successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis. Rev Gastroenterol Mex.
- Werner KT, Gallegos-Orozco JF (2012). Multiple hepatic abscesses secondary to chicken bone penetration of the colon: a case report. Rev Gastroenterol Mex, 77(1), 43-6.
- Gallegos-Orozco JF, Paskvan-Gawryletz CD, Gurudu SR, Orenstein R (2012). Successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis. Rev Gastroenterol Mex, 77(1), 40-2.
Editorial
- Gallegos-Orozco JF (2019). The Growing Challenge of Advanced Liver Disease Due to Alcohol Use in the United States. Am J Gastroenterol, 114(11), 1712-1713.
- Gallegos-Orozco JF, Charlton MR (2015). Treatment of HCV prior to liver transplantation to prevent HCV recurrence - wise or wasteful? Liver Int, 35(1), 9-11.
Abstract
- Campsen J, Kim R, Thiesset H, Chaly T, Shihab F, Ahmed F, Gallegos-Orozco JF (2016). Expanding the donor pool using HCV+ kidneys to cure HCV and end-stage renal disease. [Abstract]. American Journal of Transplantation, 16(S1), 44-45.
- Abduljawad B, Hatch J, Lynch KM, Stevens K, Thomason IR, Box TD, Gallegos-Orozco JF (2016). Real world experience with interferon-free direct acting antivirals in the treatment of patients with chronic hepatitis C. Accepted for presentation during DDW in San Diego, California, USA, May 2016. [Abstract]. Gastroenterology, 150(Supplement 1), S1104.
- Parbhu SK, Haseeb A, Gallegos-Orozco JF (01/15/2015). Ursodeoxycholic acid (UDCA) therapy in acute cytomegalovirus (CMV) hepatitis associated cholestasis. Accepted for presentation at the 80th Annual Meeting of the American College of Gastroenteorlogy in Honolulu, Hawaii. [Abstract].
- Haseeb A, Gallegos-Orozco JF (11/07/14). Hepatic encephalopathy, a preventable readmission: implementation of quality indicators at a tertiary care center. 65th Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA. [Abstract]. Hepatology, (Supp 60), 397A.
- Unzueta A, Moreira RK, De Petris G, Smith ML, Chang Y-H H, Cheng M-R, Eyshou A, Gallegos-Orozco JF, Aqel B, Vargas HE (11/07/14). Validation of the hepatitis aggressiveness score in a liver transplant population with recurrent hepatitis C. 65th Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA. [Abstract]. hepatology, (Supp 60), 535A.
- Chervenak AE, Bashar A, Byrne TJ, Carey EJ, Rakela J, Hartel LA, Gallegos-Orozco JF, Sapola AM, Vargas HE (2012). Treatment of HCV in the DAA era: the impact of a multidisciplinary team. Presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA. [Abstract]. Hepatology, 56(Suppl), 228A.
- Gallegos-Orozco JF, Chervenak AE, Carey EJ, Bashar A, Byrne TJ, Hartel LA, Rakela J, Vargas HE (2012). Liver transplant center focused experience with peginterferon alfa-2ª, ribavirin and telaprevir therapy in patients with genotype 1 hepatitis C cirrhosis. Presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases in Boston, MA, [Abstract]. Hepatology, 56(Suppl), 218A-219A.
- Gallegos-Orozco JF, Silva AM, Chang Y-H, Batheja MJ, Hansen KL, Lam-Himlin D, De Petris G, Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Mulligan DC, Silva A, Vargas HE (2012). Magnetic resonance elastography (MRE) can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Young Investigator Award Winner. Presented at the International Liver Transplantation Society 17th Annual International Congress. San Francisco, CA. [Abstract]. Liver Transpl, 18(Suppl 1), S111.
- Gallegos-Orozco JF, Silva AM, Chang Y-H, Batheja MJ, Hansen KL, Lam-Himlin D, De Petris G, Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Mulligan DC, Rakela J, Silva A, Vargas HE (2012). Magnetic resonance elastography (MRE) can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Presented at the International Liver Congress in Barcelona, Spain. [Abstract]. J Hepatol, (56), S96.
Global Impact
Education History
| Fellowship | Universidad Nacional Autónoma de México Gastroenterology Fellow |
| Residency | Universidad Nacional Autónoma de México Internal Medicine Resident |
| Professional Medical | Universidad Nacional Autónoma de México Medicine with Honors, (Suma cum Laude equivalent) M.D. |
Selected Provider Publications
Book Chapter
Unzueta A, Gallegos-Orozco JF (2017). Factores de riesgo en tumores hepaticos [Risk factors for liver tumors]. In Chirino-Sprung RA, Torre-Delgadillo A (Eds.), XII Congreso Nacional de Hepatologia (First, pp. 121-125). Mexico City: Permanyer.
Global Impact: Mexico.
Presentations
| Conference: "Factores de riesgo en tumores hepaticos" [Risk factors for liver tumors]. Presented during the XII Annual National Hepatology Congress, Mexican Hepatology Association. Merida, Yucatan, Mexico. June 21, 2017. | Mexico |
| Conference: "Abordaje inicial en hepatopatia cronica de origen oscuro: En busca de la etiologia" [Iniatial diagnostic evaluation in chronic liver disease: looking for a cause]. Presented during the XII Annual National Hepatology Congress, Mexican Hepatology Association. Merida, Yucatan, Mexico. June 21, 2017. | Mexico |